Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
fda
life sciences
national blog main
national top stories
3
×
alnylam pharmaceuticals
biotech
clinical trials
hereditary transthyretin amyloidosis
patisiran
rna interference
akcea therapeutics
alexion pharmaceuticals
andrew fire
boehringer ingelheim
craig mello
crispr
cystic fibrosis
cystic fibrosis foundation
deals
dicerna pharamceuticals
drugs
gilead sciences
hepatitis b
hepatitis b virus
hepatitis c
incivek
inotersen
jeff leiden
john maraganore
kayldeco
matt emmens
messenger rna therapeutics
new york blog main
new york top stories
nobel prize
onpattro
orkambi
What
pharmaceuticals
3
×
drug
medicines
afternoon
alnylam
alnylam’s
approved
caught
causing
cf
crisis
cystic
developer
dicerna
disease
eye
fda
fibrosis
force
gene
gets
helped
hepatitis
history
intended
jeff
landmark
leiden
making
medicine
ok
onpattro
patisiran
pay
pharma
producing
profitable
protein
research
rnai
Language
unknown
unset
Current search:
boston
×
pharmaceuticals
×
" national top stories "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
